Drug
Oraxol clinical trials
- studies test it
- 11
- open now
- 0
- in phase 3
- 1
- first study started
- 2013
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 2
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Athenex, Inc. (9) · Health Hope Pharma (1) · Kinex Pharmaceuticals Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Oraxol is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer PatientsCompletedPhase 1Health Hope PharmaNCT03165955Written as Oraxol
- The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as OraxolTerminatedPhase 1Athenex, Inc.NCT03892018Written as Oraxol
- A Study of Oraxol in Subjects With Cutaneous AngiosarcomaCompletedPhase 2Athenex, Inc.NCT03544567Written as Oraxol
- Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid TumorsTerminatedPhase 1Athenex, Inc.NCT03588039Written as Oraxol
- Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast CancerCompletedPhase 3Athenex, Inc.NCT02594371Written as Oraxol
- An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007TerminatedPhase 1Athenex, Inc.NCT04168957Written as Oraxol
- Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal CancersStatus unknownPhase 1Athenex, Inc.NCT02970539Written as Oraxol
- A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. MalignanciesCompletedPhase 1Athenex, Inc.NCT02730481Written as Oraxol
- A PK Study of Oraxol in Breast Cancer PatientsCompletedPhase 1Athenex, Inc.NCT04993040Written as Oraxol
- A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer PatientsCompletedPhase 2Athenex, Inc.NCT04180384Written as Oraxol
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced MalignanciesCompletedPhase 1Kinex Pharmaceuticals Inc.NCT01967043Written as Oraxol